Latest Trials
Latest News
FAQ
Pharmaceutical Companies
Pharma Details
North China Pharmaceutical Group Corporation
🇨🇳
China
Country
🇨🇳
China
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Efficacy and Safety Study of Shenwu Capsule
Phase 3
Completed
Conditions
Mild Cognitive Impairment
Interventions
Drug: Shenwu Capsule
Drug: Donepezil
Subscribe
First Posted Date
2011-10-14
Last Posted Date
2014-10-10
Lead Sponsor
North China Pharmaceutical Group Corporation
Target Recruit Count
324
Registration Number
NCT01451749
Locations
🇨🇳
Dongzhimen Hospital,BUCM, Beijing, China
Subscribe
Prev
1
Next
© Copyright 2024. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy